Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0001801385-24-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-28 | 2024-02-26 | KRYS | ROMANO KATHRYN | CAO | F - Tax | $157.00 | -1,533 | 11.0K | -12% | -$240.7K |
| DM | 2024-02-28 | 2024-02-26 | KRYS | ROMANO KATHRYN | CAO | S - Sale+OE | $136.91 | -8,087 | 12.6K | -39% | -$1.11M |
| DM | 2024-02-28 | 2024-02-26+ | KRYS | ROMANO KATHRYN | CAO | M - OptEx | $52.26 | +10.0K | 12.9K | +341% | +$522.6K |
| DM | 2024-02-28 | 2024-02-26+ | KRYS | ROMANO KATHRYN | CAO | M - OptEx | $0.00 | -10.0K | 5,000 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-26 | F | D | 1,533 | $157.00 | 11,023 | D | — | — | (F4) Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2024. (F5) The closing price on February 26, 2024 of the Company's common stock on NASDAQ. |
| 2 | Common | Common Stock | 2024-02-26 | S | D | 3,087 | $140.00 | 12,556 | D | — | — | (F2) The transaction was executed in multiple trades at the same sale price. |
| 3 | Common | Common Stock | 2024-02-26 | M | A | 3,087 | $52.26 | 15,643 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-26 | S | D | 5,000 | $135.00 | 12,556 | D | — | — | (F2) The transaction was executed in multiple trades at the same sale price. |
| 5 | Common | Common Stock | 2024-02-26 | M | A | 5,000 | $52.26 | 17,556 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-27 | M | A | 1,913 | $52.26 | 12,936 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-02-27 | M | D | 1,913 | $0.00 | 0 | D | $52.26 · — to 2030-01-30 | 1,913 Common Stock | (F7) 50,000 options were granted that vest in four equal annual installments beginning on January 20, 2021. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-02-26 | M | D | 3,087 | $0.00 | 1,913 | D | $52.26 · — to 2030-01-30 | 3,087 Common Stock | (F7) 50,000 options were granted that vest in four equal annual installments beginning on January 20, 2021. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-02-26 | M | D | 5,000 | $0.00 | 5,000 | D | $52.26 · — to 2030-01-30 | 5,000 Common Stock | (F7) 50,000 options were granted that vest in four equal annual installments beginning on January 20, 2021. |